Is MiNK Therapeutics, Inc. overvalued?

MiNK Therapeutics, Inc. (INKT) — key valuation metrics and fundamentals.

No verdict

Price

$12.11

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$60.3M

Dividend yield

0.0%

Return on equity

83.4%

Sector

Healthcare

Fair value compares INKT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks